Phase1 randomized placebo-controlled double blind dose-escalation study of safety tolerability pharmacokinetics pharmacodynamics & immunogenicity of intravenous dose PF-04360365 (RN119) - altzheimers (2007–2009)
- Grant type:
- Pfizer Pty Ltd
- Researchers:
-
-
Mayne Professor of Psychiatry
Medical School (Office & AME)Faculty of Medicine
-
- Funded by:
- Pfizer Pty Ltd
